Invention Grant
US08987418B2 Dual specific binding proteins directed against IL-1β and/or IL-17
有权
针对IL-1和bgr的双重特异性结合蛋白 和/或IL-17
- Patent Title: Dual specific binding proteins directed against IL-1β and/or IL-17
- Patent Title (中): 针对IL-1和bgr的双重特异性结合蛋白 和/或IL-17
-
Application No.: US14323627Application Date: 2014-07-03
-
Publication No.: US08987418B2Publication Date: 2015-03-24
- Inventor: Tariq Ghayur , JiJie Gu , Maria Harris , Carrie Goodreau , Sonal Saluja
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08 ; A61K39/395 ; A61K39/40 ; C07K16/24 ; A61K47/48 ; A61K45/06 ; C07K14/00
Abstract:
Engineered multivalent and multispecific binding proteins that bind IL-1β and/or IL-17 are provided, along with methods of making and uses in the prevention, diagnosis, and/or treatment of disease.
Public/Granted literature
- US20140356281A1 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17 Public/Granted day:2014-12-04
Information query
